Ishikawa Toru, Sato Ryo, Natsui Hiroki, Iwasawa Takahiro, Ogawa Masahiro, Kobayashi Yuji, Sato Toshifumi, Yokoyama Junji, Honma Terasu
Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Cancer Diagn Progn. 2024 Nov 3;4(6):808-813. doi: 10.21873/cdp.10400. eCollection 2024 Nov-Dec.
BACKGROUND/AIM: Although transarterial chemo-embolization (TACE) is a key treatment for hepatocellular carcinoma (HCC), its effectiveness depends on the cannulation of the microcatheter tip into the feeding artery. Steerable microcatheters allow remote operation of the tip, enabling its insertion into feeding arteries otherwise difficult to reach. This study investigated the indications and effectiveness of steerable microcatheters in TACE for HCC.
We retrospectively examined 22 patients with HCC who underwent TACE using steerable microcatheters at our Department between December 2014 and July 2024. Previous TACE administration, number of TACE sessions, and feeding artery disruption affecting TACE were examined.
Among the first TACE cases requiring steerable catheters, three demonstrated steep bifurcation of the celiac artery or superior mesenteric artery from the parent artery, two had sharp bends in the posterior segment, and four had the left hepatic artery bifurcating from the left gastric artery. All three procedures performed in the inferior phrenic artery required second TACE sessions. Steerable microcatheters were used in two patients during their eighth TACE session; both procedures involved selective cannulation of neovessels feeding from a new anastomotic branch to segment 4, following damage to the main feeding artery from repeated treatments.
Steerable microcatheters were effective in reaching steep or strongly bending branches of the parent or feeding artery in the first TACE cases or neovessels and anastomotic branches in previous TACE cases. Studies with larger sample sizes are warranted to validate the use of steerable microcatheters for effective TACE.
背景/目的:尽管经动脉化疗栓塞术(TACE)是肝细胞癌(HCC)的关键治疗方法,但其有效性取决于将微导管尖端插入供血动脉。可操纵微导管允许对尖端进行远程操作,使其能够插入难以到达的供血动脉。本研究调查了可操纵微导管在HCC的TACE中的适应证和有效性。
我们回顾性研究了2014年12月至2024年7月期间在我科接受使用可操纵微导管的TACE治疗的22例HCC患者。检查了先前的TACE治疗情况、TACE疗程数以及影响TACE的供血动脉中断情况。
在首批需要可操纵导管的TACE病例中,3例显示腹腔干动脉或肠系膜上动脉从主干动脉处急剧分叉,2例在肝叶后段有急转弯,4例左肝动脉从左胃动脉分叉。在膈下动脉进行的所有3例手术都需要进行第二次TACE疗程。在2例患者的第8次TACE疗程中使用了可操纵微导管;这2例手术均涉及在主要供血动脉因反复治疗受损后,选择性插管至从新的吻合支向肝段4供血的新生血管。
可操纵微导管在首次TACE病例中有效到达主干或供血动脉的陡峭或强烈弯曲分支,或在先前TACE病例中有效到达新生血管和吻合支。需要进行更大样本量的研究来验证可操纵微导管在有效TACE中的应用。